Abstract
The principal obligation of blood, heart, and vessels is to maintain a steady and optimal oxygen supply to the tissues. These three organs are controlled by closely integrated feedback circuits, and a change in the function in any one will cause compensatory adjustment in the function of the others. In the case of blood, acute reduction in the oxygen-carrying capacity will result in tissue hypoxia, vascular dilatation, and decreased peripheral vascular resistance, which, abetted by lower blood viscosity, will cause an increase in cardiac output and, in turn, restoration to normal of oxygen supply to the tissues. However, such a primary response by the heart to anemia is metabolically and functionally expensive and is saved for conditions of acute and severe life-threatening anemia. In patients with cancer the associated anemia is usually chronic and of moderate severity, and here the compensatory adjustments in oxygen flow rarely demand an increase in cardiac work, but are accomplished by other means, such as changes in oxygen affinity and redistribution of blood among the tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Birgegard G, Hallgren R, Killander A, et al: Serum ferritin during infection. Scand J Haematol 21: 333, 1978.
Applefeld MM, Wiernik PH: Cardiac disease after radiation therapy for Hodgkin’s disease. Analysis of 48 patients. Am J Cardiol 51: 1679, 1983.
Lenaz L, Page JA: Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev 3: 111, 1976.
Gottdiener JS, Appelbaum FR, Ferrans VJ, et al: Cardiotoxicity associated with high dose cyclophosphamide therapy. Arch Intern Med 141: 758, 1981.
Steinberg LJ, Steinherz PG, Mangiacasale D, et al: Cardiac abnormalities after AMSA administration. Cancer Ther Rep 66: 483, 1982.
Alexander J, Daniak T, Berger HJ, et al: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 300: 278, 1978.
Cartwright GE: The anemia of chronic disorders. Semin Hematol 3: 351, 1966.
Lee GR: The anemia of chronic disease. Semin Hematol 20: 61, 1983.
Reizenstein R: Hematologic Stress Syndrome. The Biologic Response to Disease. New York Praeger Scientific, 1984.
Huebers H, Finch CA: Transferrin: Physiologic behavior and clinical implications. Blood 64: 763, 1984.
Douglas SW, Adamson JW: The anemia of chronic disorders: Studies of marrow regulation and iron metabolism. Blood 45: 55, 1975.
Zucker S, Friedman S, Lysik RM: Bone marrow erythropoiesis in the anemia of infection, inflammation and malignancy. J Clin Invest 53: 1132, 1974.
Daniak N, Kulkarni V, Howard D et al: Mechanisms of abnormal erythropoiesis in malignancy. Cancer 51: 1101, 1983.
Dinarello CA: Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311: 1413, 1984.
Birgens HS: The biologic significance of lactoferrin in haematology. Scand J Haematol 33: 225, 1984.
Broxmeyer, HE: Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo. Blood Cells 10: 397, 1984.
Stryckmans, PA: Lactoferrin. No evidence for its role in the regulations of CSA production by human lymphocytes and monocytes. Blood Cells 10: 369, 1984.
Hansen NE: The anemia of chronic disorders. A bag of unsolved questions. Scand J Haematol 31: 397, 1983.
Weinberg E: Iron and neoplasms. Biol Trace Elem Res 3: 55, 1981.
Utiger RD: Decreased extrathyroidal triiodothyronine production in nonthyroidal disease. Benefit or harm? Am J Med 69: 860, 1981.
Robin ED: Of men and mitochondrias: Coping with hypoxic dysoxia. Am Rev Respir Dis 122: 517, 1980.
Bellingham AJ, Grimes AJ: Red cell 2,3 diphosphoglycerate. Br J Haematol 25: 555, 1973.
Bradley SE, Bradley GP: Renal function during chronic anemia in man. Blood 2: 192, 1947.
Schrier RW, Earley LE: Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest 49: 1656, 1970.
Duke M, Abelman WH: The hemodynamic response to chronic anemia. Circulation 39: 503, 1969.
Varat MA, Adolph RJ, Fowler NO: Cardiovascular effects of anemia. Am Heart J 83: 415, 1972.
Rosenthal DS, Handin RJ, Braunwald E: Hematologic-oncologic disorders and heart disease. In Braunwald E (ed): Heart Disease. Philadelphia, WB Saunders, 1984, p 1676.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Erslev, A.J., Caro, J. (1986). Anemia of Cancer and Its Cardiovascular Effects. In: Kapoor, A.S. (eds) Cancer and the Heart. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4898-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4898-9_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96245-0
Online ISBN: 978-1-4612-4898-9
eBook Packages: Springer Book Archive